Copyright
©The Author(s) 2017.
World J Gastroenterol. Jul 21, 2017; 23(27): 4986-5003
Published online Jul 21, 2017. doi: 10.3748/wjg.v23.i27.4986
Published online Jul 21, 2017. doi: 10.3748/wjg.v23.i27.4986
Severity | Criteria | Treatment | Comments |
First episode | |||
Stop all non-CDI related antibiotic therapy if possible | |||
Mild to moderate disease | Diarrhea and symptoms not meeting criteria for severe disease | Metronidazole 500 mg by mouth 3 times per day for 10 d to 14 d | In hospitalized patients with UC and nonsevere CDI, treatment with a vancomycin-containing regimen vs metronidazole alone resulted in fewer readmissions and shorter LOS[70] |
or | |||
Vancomycin 125 mg by mouth 4 times per day for 10 to 14 d | |||
Severe disease | Serum albumin < 3 g/dL AND one of the following: | Vancomycin 125 mg by mouth 4 times per day for 10 to 14 d | |
WBC ≥ 15000 cells/mm3 | |||
Abdominal tenderness | |||
Creatinine ≥ 133 μmol/L | |||
Severe, complicated disease | Admission to intensive care unit | Vancomycin 500 mg by mouth or nasogastric tube 4 times per day | Consider early surgical consultation |
Hypotension ± vasopressor requirement | and | ||
Fever ≥ 38.5 °C | Metronidazole 500 mg IV every 8 h | ||
Ileus | and, if ileus, | ||
Mental status changes | Vancomycin 500 mg in 500 mL saline as enema 4 times per day | ||
WBC ≥ 35000 cells/mm3 or ≤ 2000 cells/mm3 | |||
Serum lactate ≥ 2.2 mmol/L | |||
End organ failure | |||
Recurrent CDI | |||
First recurrence | Metronidazole 500 mg by mouth 3 times per day for 10 to 14 d | ||
or | |||
Vancomycin 125 mg by mouth 4 times per day for 10 to 14 d | |||
or | |||
Fidaxomicin 200 mg by mouth 2 times per day for 10 d | |||
Second recurrence | -Tapered and pulsed vancomycin | ||
or | |||
Fidaxomicin 200 mg by mouth 2 times per day for 10 d | |||
Subsequent recurrence | -Fecal microbiota transplant |
- Citation: D’Aoust J, Battat R, Bessissow T. Management of inflammatory bowel disease with Clostridium difficile infection. World J Gastroenterol 2017; 23(27): 4986-5003
- URL: https://www.wjgnet.com/1007-9327/full/v23/i27/4986.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i27.4986